Thrombotic risk management before and during pregnancy is an important medical issue that should be taken into consideration by gynecologists.
CredoMedia India starts a discussion about this crucial issue. We would like to discuss the following key points:
- When is a coagulation status test necessary when a patient is planning pregnancy or is already pregnant?
- Are conception and successful carriage of the fetus possible in cases of inherent or acquired thrombophilia?
- Is thrombophilia an obstacle for assisted reproduction?
- What is the risk of placental capillaries thrombosis in women with thrombophilia in comparison with women without that condition?
- What is the effect of auxiliary hormonal treatment on micro- and macro thrombotic risk during assisted reproduction?
- What are the drug application methods in hypercoagulable state management?
- Medication administration algorithms of low-molecular heparin
- Laboratory and clinical control of low-molecule heparin treatment
- Are there any drug interactions – how are they manifested and managed?
- The role of combined treatment – low-molecular heparin, acetylsalicylic acid etc.
- Duration of low-molecular heparin treatment and cases when it is necessary during assisted reproduction or when trying to conceive naturally after a miscarriage
We would like to invite all obstetrics and gynecology doctors specialized in assisted reproduction. We would be glad if you would share your opinion, comment or share a case study from your practice.
The discussion starts on the 1st of April and will be open for one month.